ECLIPSE

InventHelp Inventors Develop New Workout Accessory for Fitness Enthusiasts (ASP-246)

Retrieved on: 
Wednesday, December 6, 2023
Sale, Suite, ECLIPSE, Multimedia, Invention, CORE, The

Our design would keep the user's feet stable while also making the workout easier."

Key Points: 
  • Our design would keep the user's feet stable while also making the workout easier."
  • The invention provides a workout accessory for performing plank and abdominal exercises.
  • The invention features a portable and practical design that is easy to use so it is ideal for fitness enthusiasts, gyms, trainers, etc.
  • 22-ASP-246, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.

ZENAGEN, Unveils ECLIPSE: A Scientifically Advanced, Color Preservation and Anti-Gray Shampoo for All Hair Types

Retrieved on: 
Wednesday, November 15, 2023
Human, Enrichment, Science, TIME, ECLIPSE, Conditioner, Cosmetics

NASHVILLE, Tenn., Nov. 15, 2023 /PRNewswire/ -- Jared Reynolds, the esteemed Founder & CEO of ZENAGEN, is proud to announce the launch of ECLIPSE, a revolutionary advancement in hair care that melds science and beauty seamlessly. ECLIPSE Color Preservation + Anti-Gray Shampoo and Conditioner, meticulously engineered under the visionary leadership of CEO Jared Reynolds, represent a paradigm shift in the industry. They cater to the unique complexities of gray hair while ensuring that individuals with colored hair enjoy the enduring vibrancy of their chosen hue.

Key Points: 
  • ECLIPSE Color Preservation + Anti-Gray Shampoo and Conditioner, meticulously engineered under the visionary leadership of CEO Jared Reynolds, represent a paradigm shift in the industry.
  • They cater to the unique complexities of gray hair while ensuring that individuals with colored hair enjoy the enduring vibrancy of their chosen hue.
  • Our vision is to empower every individual with the opportunity to possess not just beautiful hair, but scientifically optimized hair.
  • ECLIPSE Color Preservation + Anti-Gray Shampoo and Conditioner are available for purchase on the official ZENAGEN website and through select authorized retailers.

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

Retrieved on: 
Monday, November 13, 2023
Shield, DNA, Colorectal cancer, Neoplasm, CRC, Disease, Mortality, Colonoscopy, Patient, Large intestine, Fear, ECLIPSE, Helmy Eltoukhy, Cancer, Samsung Medical Center, Medical imaging

SINGAPORE, Nov. 12, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

Key Points: 
  • SINGAPORE, Nov. 12, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
  • "The Shield blood test can broaden the range of choices for colorectal cancer screening.
  • "We are pleased to be able to help address the high rates of colorectal cancer in South Korea by introducing the Shield test at Samsung Medical Center," said Simranjit Singh, Chief Executive Officer of Guardant Health Asia, Middle East & Africa.
  • "We are confident that this revolutionary screening test will help healthcare professionals detect colorectal cancer early, when it's most treatable, with a simple blood draw."

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

Retrieved on: 
Monday, November 13, 2023
Shield, DNA, Colorectal cancer, Neoplasm, CRC, Disease, Mortality, Colonoscopy, Patient, Large intestine, Fear, ECLIPSE, Helmy Eltoukhy, Cancer, Samsung Medical Center, Medical imaging

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

Key Points: 
  • SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
  • "The Shield blood test can broaden the range of choices for colorectal cancer screening.
  • "We are pleased to be able to help address the high rates of colorectal cancer in South Korea by introducing the Shield test at Samsung Medical Center," said Simranjit Singh, Chief Executive Officer of Guardant Health Asia, Middle East & Africa.
  • "We are confident that this revolutionary screening test will help healthcare professionals detect colorectal cancer early, when it's most treatable, with a simple blood draw."

Together with Siemens Healthineers, Varian Demonstrates Commitment to Embracing Innovation and Enhancing Outcomes at ASTRO 2023

Retrieved on: 
Thursday, September 28, 2023
Ethos, Eclipse, Graphics processing unit, Communication, ECLIPSE, CBCT, KG, Annual, NUALS Arts and Literary Annual Meet, Cancer, Quality of life, EDGE, Radiation therapy, Medical examiner, Sale, ARIA, Siemens Healthineers, Radiation, Acquisition, Patient, Automation, Standard of care, User, FDA, RT, American Society for Radiation Oncology, Society, Medical imaging, Nursing, Medical device, ASTRO, Varian

PALO ALTO, Calif., Sept. 28, 2023 /PRNewswire/ -- Varian, a Siemens Healthineers company, is showcasing technologies that reflect its continued commitment to embracing innovation and enhancing outcomes for cancer patients at this year's 2023 American Society for Radiation Oncology (ASTRO) annual meeting, taking place from October 1-4 in San Diego, California.

Key Points: 
  • The solutions Varian will be highlighting at ASTRO support the company's commitment to embracing innovation and enhancing outcomes by:
    By joining forces with Siemens Healthineers, a global leader in imaging, Varian is working to expand its imaging capabilities to provide solutions with improved accuracy and quality.
  • Varian is pioneering integrated software solutions to reduce redundancies and streamline workflows to unify patient care pathways and ultimately improve outcomes.
  • VARIAN, ARIA, ECLIPSE, ETHOS, HYPERSIGHT, EDGE, and TRUEBEAM are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat.
  • Siemens Healthineers is a trademark of Siemens Trademark GmbH & Co. KG registered U.S. Pat.

Nikon introduces the digital inverted microscope, Smart Imaging System "ECLIPSE Ji"

Retrieved on: 
Thursday, September 7, 2023
Acceleration, ECLIPSE, Drug development, Nikon, Deep learning, Cancer, Graphical Data Display Manager, Research, Cell, Automation, Sale, GUI, Data analysis, Acquisition, Algorithm, Drug discovery, SE, Observation, Knowledge, Growth, NIS, AI, AX, Cranial nerve disease, Pharmaceutical industry, Television, Medical device, Medical imaging, Microscope

MELVILLE, N.Y., Sept. 7, 2023 /PRNewswire/ -- Nikon Instruments Inc. has announced the release of the smart imaging system "ECLIPSE Ji", which utilizes AI to automate the acquisition and analysis of cellular images, streamlining research workflows involving cancer and nerve disease. The smart imaging system "ECLIPSE Ji", a digital inverted microscope, will go on sale from September 8th.

Key Points: 
  • The smart imaging system "ECLIPSE Ji", a digital inverted microscope, will go on sale from September 8th.
  • Therefore, Nikon has developed the smart imaging system "ECLIPSE Ji", which uses deep learning, a type of AI, to largely automate common tasks within image acquisition and analysis workflows.
  • Furthermore, additional imaging hardware and modalities can be integrated with ECLIPSE Ji to achieve similar research capabilities as an inverted microscope.
  • In addition, the "ECLIPSE Ji" contains an integrated light source and digital camera that are placed efficiently to reduce the overall dimensions of the system.

Nikon introduces the ECLIPSE Ui Upright Microscope

Retrieved on: 
Thursday, June 15, 2023
Marie Cassidy, Associate, UI, Observation, Sale, ECLIPSE, Face, Physician, Workflow, Fatigue, Nikon, Camera, Telescopic sight

MELVILLE, N.Y., June 15, 2023 /PRNewswire/ -- Nikon Instruments Inc. is pleased to announce the development and launch of the "ECLIPSE Ui", an integrated microscope-based viewing system designed for both in-person clinical and remote pathological observation. "Nikon is proud to enter the medical product market with the introduction of the Ui. This digital microscope will greatly aid clinical pathologists with observation and collaborations while being easy to operate and comfortable to use by eliminating the need to look through eyepieces for hours at a time," Joseph LoBiondo, Associate General Manager; Product states.

Key Points: 
  • MELVILLE, N.Y., June 15, 2023 /PRNewswire/ -- Nikon Instruments Inc. is pleased to announce the development and launch of the " ECLIPSE Ui ", an integrated microscope-based viewing system designed for both in-person clinical and remote pathological observation.
  • "Nikon is proud to enter the medical product market with the introduction of the Ui.
  • The ECLIPSE Ui features a unique microscope design that foregoes eyepieces in favor of a completely digital user experience, allowing for easy viewing and sharing of images while retaining a natural posture.
  • The ECLIPSE Ui addresses both issues by providing a seamless digital-only experience, simplifying microscope operation and remote collaboration, while entirely avoiding the discomfort associated with manual observation through the eyepieces.

Transphorm Wins $15 Million Contract from the National Security Technology Accelerator

Retrieved on: 
Tuesday, May 23, 2023
Internet, Electronic Design Automation, Data Management, Technology, Apps, Applications, Semiconductor, Mobile, Wireless, Security, Power, Knowledge, RF, ECLIPSE, Gallium nitride, MOCVD, Transphorm

Transphorm, Inc. (Nasdaq: TGAN)—global leader in fundamentally superior, quantitatively outperforming GaN power semiconductors—today announced it has been awarded a contract for up to $15 million from the National Security Technology Accelerator (NSTXL).

Key Points: 
  • Transphorm, Inc. (Nasdaq: TGAN)—global leader in fundamentally superior, quantitatively outperforming GaN power semiconductors—today announced it has been awarded a contract for up to $15 million from the National Security Technology Accelerator (NSTXL).
  • The contract is for the ECLIPSE Project, under which Transphorm is commissioned to manufacture advanced GaN epiwafers.
  • The company’s opportunity to contribute to this Project underscores Transphorm’s IP, knowledge, and expertise in the advanced GaN materials sector as well as its MOCVD manufacturing infrastructure.
  • Transphorm’s experience in GaN epiwafer design, development, and production of various breakthrough high voltage GaN platforms spans more than ten years.

Nikon introduces the ECLIPSE Ni-L Upright Microscope

Retrieved on: 
Tuesday, May 23, 2023
Maintenance, ECLIPSE, Microscope, Nikon, Overalls, Life expectancy, LED, NCB, Risk, Observation, AI, Environment, CO2, Camera

MELVILLE, N.Y., May 23, 2023 /PRNewswire/ -- Nikon Instruments Inc. announced the release of the ECLIPSE Ni-L upright microscope which features specially balanced LED illumination with properties similar to natural light. This results in more accurate displays of the original color rendition of the specimen, making it particularly effective for the observation of pathological specimens and cells.

Key Points: 
  • Nikon has developed the ECLIPSE Ni-L upright microscope equipped with a more balanced natural color LED light source that renders truer microscope images.
  • Since the color of LED light is stable, color information and images can be achieved with high color reproducibility when imaging specimens using microscope digital cameras and NIS-Elements imaging software .
  • Microscopes using a halogen light source are designed with externally attached lamp housings in order to facilitate regular light source replacement.
  • The ECLIPSE Ni-L, due to longer life expectancy of LED light sources, has the illumination built-in resulting in an overall size reduction of 150 mm.

Guardant Health Reports First Quarter 2023 Financial Results

Retrieved on: 
Tuesday, May 9, 2023
Biotechnology, Pharmaceutical, Health, Oncology, ASP, Partnership, ECLIPSE, Shield, CRC, Marketing, Liquid biopsy, Lung cancer, GAAP, GH, Forecasting, MRD, Medicare, Net, DDW, Helmy Eltoukhy, EBITDA, PMA, Acquisition, Webcast, Depreciation, Growth, FDA, Breast cancer, Mobile phone, Video game, Pharmaceutical industry, Bank, Insurance

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2023.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2023.
  • Precision oncology gross margin was 60% in the first quarter of 2023, as compared to 64% in the prior year period.
  • Guardant Health expects full year 2023 revenue to be in the range of $535 million to $545 million, representing growth of 19% to 21% compared to full year 2022.
  • Guardant Health will host a conference call to discuss the first quarter and full year 2023 financial results after market close on Tuesday, May 9, 2023 at 1:30 pm Pacific Time / 4:30 pm Eastern Time.